Your Portfolio

120
20600
6 mo60 mo

20%90%
$500$5,000

$10K$200K
150
Net Annual ROI
$0
0x return
Adjust the sliders to see your estimate.
Time saved
months to enrollment per trial
Screen-fail savings
annual across portfolio
Delay cost avoided
annual across portfolio
Syncra cost
annual (subscription + per-patient)
Value breakdown — annual
Screen-fail reduction
$0
Trial delay avoided
$0

Total gross value
$0
Syncra annual cost
$0

Net annual ROI
$0

Enrollment time reduction

Predictive EHR scoring + multi-site coordination benchmarks suggest 30–40% reduction in time-to-full-enrollment for AI-assisted trials. We use 35% as the midpoint.

Screen-fail savings formula

// Screened patients per trial = enrolled ÷ (1 − screen_fail_rate) screened_per_trial = target_n ÷ (1 − sfr) // Syncra reduces screen-fail rate by 35% of the overage // (bad matches filtered before they hit a screening visit) avoidable_screens = screened_per_trial × sfr × 0.35 sf_savings_per_trial = avoidable_screens × cost_per_screen_visit annual_sf_savings = sf_savings_per_trial × num_trials

Delay cost avoidance formula

// Time saved per trial (months) time_saved = enrollment_months × 0.35 // Delay cost = sites × months saved × cost per site per month delay_savings_per_trial = sites × time_saved × delay_cost_per_site_month annual_delay_savings = delay_savings_per_trial × num_trials

Default $40,000/site/month is Phase II benchmark from Tufts CSDD (includes site staff, IRB fees, monitoring, and opportunity cost). Phase III typically runs $80K–$120K/site/month.

Syncra pricing

// $3,000/month per active trial network subscription_cost = num_trials × 3000 × 12 // $400 per enrolled patient across portfolio per_patient_cost = num_trials × target_n × 400 annual_cost = subscription_cost + per_patient_cost

Net ROI & ROI multiple

gross_value = annual_sf_savings + annual_delay_savings net_roi = gross_value − annual_cost roi_multiple = gross_value ÷ annual_cost

ROI multiple is gross value divided by cost — how many dollars returned per dollar spent. Net ROI is the dollar surplus.

What this doesn't include

  • Staff time savings (coordinator hours freed from manual chart review — typically 15–20 hrs/week/site)
  • Improved data quality and reduced protocol deviations from AI-assisted screening
  • Patient retention improvements (Syncra agents maintain engagement post-screen)
  • Cross-trial learnings compounding over time

All estimates are conservative. Real-world deployments typically show higher returns once staff reallocation is included.

These numbers real for your portfolio?

Book a 20-minute walkthrough. We'll verify the math against your actual trial data and show you the live dashboard.

Talk to the team →
Seen enough? Request a pilot